SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: JEB who wrote (211)1/12/1999 6:36:00 AM
From: QuietWon  Respond to of 2515
 
JEB, good find. Again,IMCL has MANY AND DIFFERENT in pipeline, any and all, can hit big, any one of which can propel the stock forward significantly.

Again, for your $, you get

1.BEC2 - Phase III already - lung cancer

2.C225 - about to go into Phase III - awaiting approval
a) head and neck
b) Karposi sarcoma - AIDS
c) many other applications of the compound

3.Stem cell



To: JEB who wrote (211)1/12/1999 6:38:00 AM
From: QuietWon  Respond to of 2515
 
Another diff btwn Entremed & IMCL - IMCL tested and works on HUMANS, emed only mice


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News